scispace - formally typeset
Open AccessJournal ArticleDOI

Pro-resolving lipid mediators are leads for resolution physiology

Charles N. Serhan
- 05 Jun 2014 - 
- Vol. 510, Iss: 7503, pp 92-101
Reads0
Chats0
TLDR
The mechanisms of specialized pro-resolving mediators and omega-3 essential fatty acid pathways that could help us to understand their physiological functions are covered.
Abstract
Advances in our understanding of the mechanisms that bring about the resolution of acute inflammation have uncovered a new genus of pro-resolving lipid mediators that include the lipoxin, resolvin, protectin and maresin families, collectively called specialized pro-resolving mediators. Synthetic versions of these mediators have potent bioactions when administered in vivo. In animal experiments, the mediators evoke anti-inflammatory and novel pro-resolving mechanisms, and enhance microbial clearance. Although they have been identified in inflammation resolution, specialized pro-resolving mediators are conserved structures that also function in host defence, pain, organ protection and tissue remodelling. This Review covers the mechanisms of specialized pro-resolving mediators and omega-3 essential fatty acid pathways that could help us to understand their physiological functions.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Inverse Relationship between Serum Lipoxin A4 Level and the Risk of Metabolic Syndrome in a Middle-Aged Chinese Population.

TL;DR: Investigation of the relationship between serum lipoxin A4 (LXA4) level and the risk of incident MetS in a middle-aged Chinese population suggests that serum LXA4 levels might be useful for early detection and prevention of Mets.
Journal ArticleDOI

Can pleiotropic effects of eicosapentaenoic acid (EPA) impact residual cardiovascular risk

TL;DR: The literature shows that EPA can robustly lower plasma triglyceride levels without raising LDL-C levels and documents EPA to have a broad range of beneficial effects on the atherosclerotic pathway, including those on lipids, lipoproteins, inflammation, oxidation, phospholipid membranes, and the atheosclerotic plaque itself.
References
More filters
Journal ArticleDOI

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

TL;DR: A better understanding of the molecular basis of myelomonocytic cell plasticity will open new vistas in immunopathology and therapeutic intervention and provide a paradigm for macrophage plasticity and function.
Journal ArticleDOI

Resolution of inflammation: the beginning programs the end.

TL;DR: Emerging evidence now suggests that an active, coordinated program of resolution initiates in the first few hours after an inflammatory response begins, and the mechanism required for inflammation resolution may underpin the development of drugs that can resolve inflammatory processes in directed and controlled ways.
Journal ArticleDOI

Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals.

TL;DR: It is reported that lipidomic analysis of exudates obtained in the resolution phase from mice treated with ASA and docosahexaenoic acid produce a novel family of bioactive 17R-hydroxy-containing di- and tri-Hydroxy-docosanoids termed resolvins.
Journal ArticleDOI

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

TL;DR: Monotherapy blocking IL-1 activity in autoinflammatory syndromes results in a rapid and sustained reduction in disease severity, including reversal of inflammation-mediated loss of sight, hearing and organ function.
Related Papers (5)